{"transactions":[{"id":2352999,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-03-04T00:12:51.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":8954,"price":0.821,"value":7351.234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":212327,"source":{"system":"sec-edgar","filing":"0001209191-22-015893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122015893/doc4.xml","form_type":"4"}},{"id":2391331,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:03:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":221281,"source":{"system":"sec-edgar","filing":"0001209191-22-010384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010384/doc4.xml","form_type":"4"}},{"id":2599393,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-08-17T13:11:24.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":6000,"price":1.63,"value":9780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":95281,"source":{"system":"sec-edgar","filing":"0001209191-21-051759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121051759/doc4.xml","form_type":"4"}},{"id":2805413,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-05T12:05:07.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":1953,"price":2.56,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":89281,"source":{"system":"sec-edgar","filing":"0001209191-21-018054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121018054/doc4.xml","form_type":"4"}},{"id":2811647,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:14.000Z","date":"2021-03-03","kind":"purchase","acquired":true,"shares":2500,"price":3.03,"value":7575.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":87328,"source":{"system":"sec-edgar","filing":"0001209191-21-017569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017569/doc4.xml","form_type":"4"}},{"id":2811646,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:14.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":68450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":84828,"source":{"system":"sec-edgar","filing":"0001209191-21-017569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017569/doc4.xml","form_type":"4"}},{"id":3051920,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2020-08-19T21:00:08.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":2000,"price":2.5,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":16377,"source":{"system":"sec-edgar","filing":"0001209191-20-047533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919120047533/doc4.xml","form_type":"4"}},{"id":3230887,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2020-03-04T01:27:29.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":673,"price":2.93,"value":1971.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":14628,"source":{"system":"sec-edgar","filing":"0001209191-20-015801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919120015801/doc4.xml","form_type":"4"}},{"id":3363925,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-21T00:35:42.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":350000,"price":0.1,"value":35000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":827817,"source":{"system":"sec-edgar","filing":"0001209191-19-057511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119057511/doc4.xml","form_type":"4"}},{"id":3448748,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-08-03T00:36:49.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":1236,"price":0.403,"value":498.108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":477817,"source":{"system":"sec-edgar","filing":"0001209191-19-044367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119044367/doc4.xml","form_type":"4"}},{"id":3610734,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-03-06T02:01:29.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":407703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As reported on the Current Report on Form 8-K filed on February 15, 2019 and pursuant to the reporting person's appointment as CEO, the securities reported represent shares underlying a restricted stock unit, of which shares will vest in four equal annual installments. Additionally, the reporting person's right to receive the underlying shares at vesting is subject to stockholder approval of an increase in the authorized shares under the Company's equity compensation plan. In the event that such an increase is not approved, then no shares will be issued at the applicable vesting date."}],"balance_after":479053,"source":{"system":"sec-edgar","filing":"0001209191-19-017201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119017201/doc4.xml","form_type":"4"}},{"id":3653247,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common stock","published_at":"2019-02-16T02:00:33.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":71350,"source":{"system":"sec-edgar","filing":"0001209191-19-010820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119010820/doc4.xml","form_type":"4"}},{"id":3852765,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-08-04T01:28:59.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in four equal annual installments."}],"balance_after":16000,"derivative":{"exercise_price":1.79,"expiration_date":"2028-08-01","underlying":"Common stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-18-045455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919118045455/doc4.xml","form_type":"4"}},{"id":3852764,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-08-04T01:28:59.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":16350,"source":{"system":"sec-edgar","filing":"0001209191-18-045455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919118045455/doc4.xml","form_type":"4"}},{"id":4272358,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-06-26T12:23:26.000Z","date":"2017-06-23","kind":"purchase","acquired":true,"shares":3500,"price":0.62,"value":2170.0,"ownership":{"direct":true},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001209191-17-041790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919117041790/doc4.xml","form_type":"4"}},{"id":4344408,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2017-04-26T22:36:13.000Z","date":"2017-04-24","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date."}],"balance_after":95000,"derivative":{"exercise_price":0.65,"expiration_date":"2027-04-24","underlying":"Common stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-17-028260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919117028260/doc4.xml","form_type":"4"}}]}